News
CYRX
17.78
-1.88%
-0.34
Cryoport Inc: Statement of changes in beneficial ownership of securities
Press release · 1d ago
Weekly Report: what happened at CYRX last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at CYRX last week (0311-0315)?
Weekly Report · 03/18 09:33
Analyst Ratings For CryoPort
4 analysts have expressed a variety of opinions on CryoPort (NASDAQ:CYRX) over the past quarter. The company has an average price target of $17.75 and 12-month price targets of $19.00. Cryo Port is a provider of temperature-controlled supply chain solutions to the life sciences industry. The analysts have an average rating of 'neutral' for the company.
Benzinga · 03/15 14:00
Cryoport Is Maintained at Neutral by UBS
Dow Jones · 03/15 12:58
UBS Maintains Neutral on CryoPort, Raises Price Target to $17
Benzinga · 03/15 12:48
Analysts Conflicted on These Industrial Goods Names: CryoPort (CYRX) and The Middleby (MIDD)
TipRanks · 03/15 05:30
Cryoport Tanks On Chilling Results And Bad Decisions
Cryoport, Inc.'s financial results for Q4 2023 fell short of expectations, with revenue declining and a significant net loss. On March 13th, shares of Cryoport plunged 11.9%. The company provides customers with supply chain solutions. Management's decision to buy back shares instead of focusing on growth raises concerns about the company's future prospects.
Seeking Alpha · 03/14 15:56
Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday
Build-A-Bear Workshop shares jumped 15.7% to $29.20 on Thursday. The company reported better-than-expected fourth-quarter results but missed on revenue. The Dow Jones index fell more than 100 points in Thursday's session. Turtle Beach Corporation and DICK'S Sporting Goods also recorded gains.
Benzinga · 03/14 14:38
Cryoport Price Target Maintained With a $17.00/Share by Stephens & Co.
Dow Jones · 03/13 16:06
Stephens & Co. Reiterates Equal-Weight on CryoPort, Maintains $17 Price Target
Benzinga · 03/13 15:56
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NuCana (NASDAQ:NCNA) shares moved upwards by 110.6% to $0.81 during Wednesday's pre-market session. HUTCHMED (China) stock increased by 14.04% in the pre- market session. Kintara Therapeutics (NASdaq:KTRA) and Qilian Intl. Gr (Qilian) were among the losers.
Benzinga · 03/13 13:06
Cryoport Is Maintained at Buy by Needham
Dow Jones · 03/13 10:49
Cryoport Price Target Cut to $18.00/Share From $19.00 by Needham
Dow Jones · 03/13 10:49
CryoPort Endorsed with ‘Buy’ Rating Amid Robust Commercial Growth and Dominant C&GT Market Presence
Needham reiterated a Buy rating on CryoPort (CYRX – Research Report) with a price target of $18.00. The company is a major player in the clinical trial market for cell and gene therapies. BTIG also maintained a Buy Rating on the stock with a $20.00 price target.
TipRanks · 03/13 10:45
Needham Maintains Buy on CryoPort, Lowers Price Target to $18
Benzinga · 03/13 10:39
CryoPort’s Growth Trajectory: Navigating Temporary Setbacks with Strategic Acquisitions and Biopharma Recovery
David Larsen from BTIG maintained a Buy rating on CryoPort (CYRX – Research Report), with a price target of $20.00. Larsen is optimistic about the company’s growth prospects despite a revenue miss in the most recent quarter. The analyst expects the biopharma spending environment to gradually recover through 2024.
TipRanks · 03/13 10:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
NuCana (NASDAQ:NCNA) stock rose 157.2% to $0.99 during Tuesday's after-market session. The company's market cap rose to $52.2 million. NuCana shares were the top gainers in the day.
Benzinga · 03/12 21:33
CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates
NASDAQ · 03/12 21:30
*Cryoport Sees 2024 Rev $242M-$252M >CYRX
Dow Jones · 03/12 20:17
More
Webull provides a variety of real-time CYRX stock news. You can receive the latest news about Cryoport Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYRX
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.